NCT05162157

Home Spirometry in Primary Care: an Implementation Study

Home Spirometry for the Diagnosis and Monitoring of Asthma and COPD in Primary Care in The Netherlands and Sweden: an Implementation Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 144 (actual)
• Sponsor: General Practitioners Research Institute · Network
• Sex: All
• Age: 16 Years
• Healthy volunteers: Not accepted

Summary

Rationale: Spirometry is essential in the diagnosis of airway disease and can be useful in monitoring patients. Despite the essential role, spirometry remains largely underused in primary care. Due to Coronavirus disease (COVID-19), the use of office spirometry is contraindicated in many countries. Furthermore, spirometric devices are costly and personnel requires special training. Referral for spirometry increases the cost for patients and lowers the feasibility. Part of the reason for underdiagnosis of airway disease are the specific situations (such as exercise-induced asthma) in which spirometry in office setting might not reveal abnormalities. In recent years, handheld spirometry linked to phones/apps has been developed for study purposes and remote monitoring. Objective: To study the feasibility, quality and added value of at-home spirometry for the diagnosis and monitoring of asthma and Chronic Obstructive Pulmonary Disease (COPD) in primary care.

Conditions

• COPD Asthma

Interventions

Type	Name	Description
DEVICE	NuvoAir platform	Nuvoair platform, consisting of a bluetooth spirometer, smartphone application and clinical portal

Timeline

• Start date: 2021-09-27
• Primary completion: 2022-12-28
• Completion: 2022-12-28
• First posted: 2021-12-17
• Last updated: 2023-02-23

Locations

2 sites across 2 countries: Netherlands, Sweden